Apollon Wealth Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,997
Closed -$206K 1627
2026
Q1
$206K Buy
3,997
+212
+6% +$14.8K ﹤0.01% 1308
2025
Q4
$349K Sell
3,785
-6
-0.2% -$574 0.01% 995
2025
Q3
$281K Sell
3,791
-424
-10% -$42.9K 0.01% 1077
2025
Q2
$547K Buy
4,215
+16
+0.4% +$2.32K 0.01% 768
2025
Q1
$669K Buy
4,199
+19
+0.5% +$3.44K 0.01% 627
2024
Q4
$775K Sell
4,180
-229
-5% -$44.5K 0.02% 598
2024
Q3
$931K Sell
4,409
-15
-0.3% -$2.61K 0.03% 516
2024
Q2
$592K Buy
4,424
+4
+0.1% +$757 0.02% 617
2024
Q1
$949K Sell
4,420
-1
-0% -$196 0.03% 492
2023
Q4
$899K Sell
4,421
-52
-1% -$8.43K 0.03% 484
2023
Q3
$888K Sell
4,473
-16
-0.4% -$4.04K 0.04% 389
2023
Q2
$1.46M Sell
4,489
-457
-9% -$131K 0.07% 289
2023
Q1
$1.16M Sell
4,946
-180
-4% -$45.5K 0.07% 290
2022
Q4
$1.29M Sell
5,126
-1
-0% -$213 0.09% 230
2022
Q3
$909K Sell
5,127
-14
-0.3% -$2.81K 0.07% 276
2022
Q2
$939K Sell
5,141
-376
-7% -$75K 0.08% 277
2022
Q1
$1.42M Buy
+5,517
New +$1.26M 0.1% 209

Other funds holding INSP

Apollon Wealth Management's INSP Position: Q2 2026 in Review

Apollon Wealth Management sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 3,997 shares — an estimated $206K sold.

Apollon Wealth Management first reported a position in INSP in Q1 2022 and held it in 17 quarters. The position peaked at $1.46M in Q2 2023. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Apollon Wealth Management reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Apollon Wealth Management sold 3,997 Inspire Medical Systems shares in Q2 2026, an estimated $206K.
  • Apollon Wealth Management first reported a position in Inspire Medical Systems in Q1 2022 and held it in 17 quarters.
  • Apollon Wealth Management's Inspire Medical Systems position peaked at $1.46M in Q2 2023.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.